Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)
- Status
- TERMINATED
- Phase
- PHASE4
Montelukast in Very Low Birthweight Infants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of CL Wear Between Two Allergy Drops
- Status
- WITHDRAWN
- Phase
- PHASE4
A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating Simvastatin's Potential Role in Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
- Status
- COMPLETED
- Phase
- PHASE3
Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of MK0359 in Patients With Chronic Asthma (0359-013)
- Status
- COMPLETED
- Phase
- PHASE2
MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)
- Status
- COMPLETED
- Phase
- PHASE2